Year |
Citation |
Score |
2015 |
Frank CU, Braeth S, Dietrich JW, Wanjura D, Loos U. Bridge Technology with TSH Receptor Chimera for Sensitive Direct Detection of TSH Receptor Antibodies Causing Graves' Disease: Analytical and Clinical Evaluation. Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et MéTabolisme. 47: 880-8. PMID 26079838 DOI: 10.1055/S-0035-1554662 |
0.592 |
|
2015 |
Frank CU, Braeth S, Dietrich JW, Wanjura D, Loos U. Bridge Technology with TSH Receptor Chimera for Sensitive Direct Detection of TSH Receptor Antibodies Causing Graves’ Disease: Analytical and Clinical Evaluation Hormone and Metabolic Research. DOI: 10.1055/s-0035-1554662 |
0.543 |
|
2007 |
Franz C, Minich W, Büsselmann I, Loos U. Direct quantification of stimulating TSH receptor autoantibodies in Graves' disease by the first in vitro assay suitable for routine clinical diagnosis Experimental and Clinical Endocrinology & Diabetes. 115. DOI: 10.1055/S-2007-972424 |
0.356 |
|
2005 |
Breous E, Wenzel A, Loos U. The promoter of the human sodium/iodide symporter responds to certain phthalate plasticisers. Molecular and Cellular Endocrinology. 244: 75-8. PMID 16257484 DOI: 10.1016/J.Mce.2005.06.009 |
0.305 |
|
2003 |
Breous E, Wenzel A, Loos U. Graves' IgG activate upstream enhancer of the sodium/iodide symporter. Molecular and Cellular Endocrinology. 213: 109-13. PMID 15062579 DOI: 10.1016/J.Mce.2003.10.039 |
0.347 |
|
2002 |
Schmitt TL, Espinoza CR, Loos U. Characterization of a thyroid-specific and cyclic adenosine monophosphate-responsive enhancer far upstream from the human sodium iodide symporter gene Thyroid. 12: 273-279. PMID 12034050 DOI: 10.1089/10507250252949388 |
0.334 |
|
2001 |
Espinoza CR, Schmitt TL, Loos U. Thyroid transcription factor 1 and Pax8 synergistically activate the promoter of the human thyroglobulin gene Journal of Molecular Endocrinology. 27: 59-67. PMID 11463576 DOI: 10.1677/Jme.0.0270059 |
0.327 |
|
2000 |
Minich WB, Weymayer JD, Loos U. Immunoprecipitation analysis of pathological autoantibodies in Graves' patients' sera using biotinylated human thyrotropin receptor labeled with 125I-neutravidiny. Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association. 107: 555-60. PMID 10612487 DOI: 10.1055/S-0029-1232565 |
0.381 |
|
1998 |
Minich WB, Weymayer JD, Loos U. Expression of a biotinylated human thyrotropin receptor in HeLa cells using recombinant vaccinia virus and its application for the detection of Graves' autoantibodies. Thyroid : Official Journal of the American Thyroid Association. 8: 3-7. PMID 9492146 DOI: 10.1089/Thy.1998.8.3 |
0.361 |
|
1997 |
Minich WB, Behr M, Loos U. Expression of a functional tagged human thyrotropin receptor in HeLa cells using recombinant vaccinia virus. Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association. 105: 282-90. PMID 9354857 DOI: 10.1055/S-0029-1211766 |
0.374 |
|
1997 |
Behr M, Ramsden DB, Loos U. Deoxyribonucleic acid binding and transcriptional silencing by a truncated c-erbA beta 1 thyroid hormone receptor identified in a severely retarded patient with resistance to thyroid hormone. The Journal of Clinical Endocrinology and Metabolism. 82: 1081-7. PMID 9100577 DOI: 10.1210/Jcem.82.4.3853 |
0.306 |
|
1997 |
Behr M, Loos U. Periodically hyperthyroid phenotype in thyroid hormone resistance is associated with mutation D322N in the thyroid hormone receptor beta gene: transcriptional properties of the mutant and the role of retinoid X receptor. Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association. 111-6. PMID 8981016 DOI: 10.1055/S-0029-1211716 |
0.336 |
|
1995 |
Loos U, Hagner S, Bohr UR, Bogatkewitsch GS, Jakobs KH, Van Koppen CJ. Enhanced cAMP accumulation by the human thyrotropin receptor variant with the Pro52Thr substitution in the extracellular domain. European Journal of Biochemistry. 232: 62-5. PMID 7556171 DOI: 10.1111/J.1432-1033.1995.Tb20781.X |
0.352 |
|
1994 |
Bohr UR, Behr M, Loos U. A heritable point mutation in an extracellular domain of the TSH receptor involved in the interaction with Graves' immunoglobulins. Biochimica Et Biophysica Acta. 1216: 504-8. PMID 8268237 DOI: 10.1016/0167-4781(93)90024-8 |
0.309 |
|
1992 |
Behr M, Loos U. A point mutation (Ala229 to Thr) in the hinge domain of the c-erbA beta thyroid hormone receptor gene in a family with generalized thyroid hormone resistance. Molecular Endocrinology (Baltimore, Md.). 6: 1119-26. PMID 1324420 DOI: 10.1210/Mend.6.7.1324420 |
0.336 |
|
1991 |
Duntas L, Keck FS, Rosenthal J, Wolf C, Loos U, Pfeiffer EF. Single-compartment model analysis of thyrotropin-releasing hormone kinetics in hyper- and hypothyroid patients. Kinetic studies using a combined system of RIA and FPLC. Klinische Wochenschrift. 68: 1013-9. PMID 2126579 DOI: 10.1007/Bf01646547 |
0.364 |
|
1989 |
Stryjek-Kaminska D, Loos U, Maier V, Ditschuneit HH, Pfeiffer EF. Seasonal variations of glucose and triiodothyronine concentrations in serum of carp (Cyprinus carpio L). Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme. 20: 727-9. PMID 3220447 DOI: 10.1055/S-2007-1010932 |
0.306 |
|
1989 |
Loos U, VAN MIDDLESWORTH L, KECK FS, PFEIFFER EF. Detection of radioactive pollution by measuring 131iodine content in cattle thyroids – a follow up since 1974 Acta Endocrinologica. 120: S35. DOI: 10.1530/Acta.0.120S035 |
0.315 |
|
1988 |
Duntas L, Keck FS, Loos U, Pfeiffer EF. [Pharmacokinetics and pharmacodynamics of protirelin (TRH) in man]. Deutsche Medizinische Wochenschrift (1946). 113: 1354-7. PMID 3137012 DOI: 10.1055/S-2008-1067819 |
0.32 |
|
1987 |
Loos U, HAUSDORF S, CLEMENT J, PFEIFFER EF. Detection of a protein highly responsive to 3,5,3′-triiodothyronine (T3) administration in 3T3-L1-adipocytes Acta Endocrinologica. 116: S84. DOI: 10.1530/Acta.0.114S084 |
0.31 |
|
1986 |
Keck FS, Loos U, Duntas L, Pfeiffer EF. [Acute factitious hyperthyroidism--moderate clinical symptoms in 3 cases under beta-blocker treatment]. Klinische Wochenschrift. 64: 319-26. PMID 3713106 DOI: 10.1007/Bf01711950 |
0.321 |
|
1981 |
Loos U, Konrad F, Pfeiffer EF. [T3-hyperthyroidism under the aspects of secretion and peripheral production of thyroid hormones (author's transl)]. Klinische Wochenschrift. 59: 495-500. PMID 7241949 DOI: 10.1007/Bf01696211 |
0.313 |
|
1978 |
Loos U, Raptis S, Birk J, Escobar-Jimenez F, Meyer G, Rothenbuchner G, Pfeiffer EF. Inhibition of TSH-stimulated radioiodine turnover and release of T4 and T3 in vivo by somatostatin. Metabolism: Clinical and Experimental. 27: 1269-73. PMID 682991 DOI: 10.1016/0026-0495(78)90057-4 |
0.383 |
|
1975 |
Rothenbuchner G, Koutras DA, Raptis S, Birk J, Loos U, Rigopoulos G, Malamos B. The effect of thyrotrophin-releasing hormone on serum TSH, T-4, and T-3 levels in endemic and sporadic nontoxic goitre. Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme. 6: 501-6. PMID 4217759 DOI: 10.1055/S-0028-1093797 |
0.356 |
|
1975 |
Loos U, Ishihara A, Rothenbuchner G, Adam WE. MEASUREMENTS OF ENDOGENOUSLY LABELLED THYROXINE (T4) AND TRIIODOTHYRONINE (T3 IN SERUM AFTER ADMINISTRATION OF TRACER AMOUNTS OF RADIOIODINE IN MAN Acta Endocrinologica. 80: S11. DOI: 10.1530/Acta.0.080S011A |
0.314 |
|
1974 |
L'Hermite M, Robyn C, Golstein J, Rothenbuchner G, Birk J, Loos U, Bonnyns M, Vanhaelst L. Prolactin and thyrotropin in thyroid diseases: lack of evidence for a physiological role of thyrotropin-releasing hormone in the regulation of prolactin secretion. Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme. 6: 190-5. PMID 4209662 DOI: 10.1055/S-0028-1093871 |
0.353 |
|
1974 |
Ishihara A, Loos U, Rothenbuchner G, Pfeiffer EF. THYROXINE (T4) ASSAY IN URINE AS AN INDEX FOR THE DIAGNOSIS OF THYROID FUNCTION Acta Endocrinologica. 77: S79. DOI: 10.1530/Acta.0.077S079 |
0.358 |
|
1973 |
Rothenbuchner G, Birk J, Loos U, Raptis S, Fletcher S, Pfeiffer EF. [Studies on 125-iodine-labeled synthetic thyrotropin-releasing hormone (TRH)]. Klinische Wochenschrift. 51: 412-4. PMID 4197611 DOI: 10.1007/Bf01468091 |
0.312 |
|
Show low-probability matches. |